The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy

Chun Te Wu, Wen Cheng Chen, Shuen Kuei Liao, Cheng Lung Hsu, Kuan Der Lee, Miao Fen Chen

研究成果: 雜誌貢獻文章同行評審

23 引文 斯高帕斯(Scopus)

摘要

Hormone therapy for prostate cancer eventually fails leading to a stage called hormone-resistant (HR) disease. To investigate the issue about the characteristics and the radiation response in HR prostate cancer, we established HR cell sub-lines, 22RV1-F and 22RV1-DF, from 22RV1 cells with androgen deprivation for 16 weeks, and obtained LNCaP-HR from LNCaP with long-term bicalutamide treatment. We examined their sensitivities to radiation therapy and the underlying mechanisms. In vitro and in vivo faster tumor growth rate was noted in the HR prostate cancer cells when compared with control. Moreover, HR prostate cancer cells had greater capacity to scavenge reactive oxygen species, and suffered less apoptosis and senescence, and subsequently were more likely to survive from irradiation as measured by clonogenic assay in vitroana growth delay in vivo. The decreased p53 and increased mouse double minute 2 oncogene (MDM2) might be the potential underlying mechanisms for the more aggressive growth and more radioresistance in H R prostate cancer cells. In conclusion, HR prostate cancer cells appeared to be more aggressive in tumor growth and in resistance to radiation treatment. Regulation of the expressions of p53 and MDM2 should be the promising treatment strategies for relative radioresistant prostate cancer.
原文英語
頁(從 - 到)633-643
頁數11
期刊Endocrine-Related Cancer
14
發行號3
DOIs
出版狀態已發佈 - 九月 2007
對外發佈

ASJC Scopus subject areas

  • 內分泌
  • 腫瘤科
  • 癌症研究
  • 內分泌學、糖尿病和代謝

指紋

深入研究「The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy」主題。共同形成了獨特的指紋。

引用此